Zobrazeno 1 - 10
of 504
pro vyhledávání: '"Denner, K."'
Autor:
Davies J; School of Psychology, Faculty of Medicine, Health and Life Science, Vivian Tower, Swansea University, Swansea, SA2 8PP, UK., McKenna M; Down to Earth Project, Swansea, UK., Denner K; Down to Earth Project, Swansea, UK., Bayley J; Down to Earth Project, Swansea, UK., Morgan M; School of Psychology, Faculty of Medicine, Health and Life Science, Vivian Tower, Swansea University, Swansea, SA2 8PP, UK.
Publikováno v:
Journal of mental health (Abingdon, England) [J Ment Health] 2024 Apr; Vol. 33 (2), pp. 218-226. Date of Electronic Publication: 2022 May 10.
Autor:
Bothe U; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Günther J; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Nubbemeyer R; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Siebeneicher H; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Ring S; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Bömer U; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Peters M; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Rausch A; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Denner K; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Himmel H; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Sutter A; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Terebesi I; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Lange M; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Wengner AM; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Guimond N; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Thaler T; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Platzek J; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Eberspächer U; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Schäfer M; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Steuber H; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Zollner TM; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Steinmeyer A; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany., Schmidt N; Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Jan 25; Vol. 67 (2), pp. 1225-1242. Date of Electronic Publication: 2024 Jan 16.
Autor:
Reif S; Clinical Pharmacology, Bayer AG Research and Development, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany. stefanie.reif@bayer.com., Schultze-Mosgau MH; Clinical Pharmacology, Bayer AG Research and Development, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany., Engelen A; Bayer AG Research and Development, Pharmaceuticals, Wuppertal, Germany., Piel I; Bayer AG Research and Development, Pharmaceuticals, Wuppertal, Germany., Denner K; Clinical Pharmacology, Bayer AG Research and Development, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany., Roffel A; ICON Plc (Formerly PRA Health Sciences), Van Swietenlaan 6, 9728 NZ, Groningen, The Netherlands., Tiessen R; ICON Plc (Formerly PRA Health Sciences), Van Swietenlaan 6, 9728 NZ, Groningen, The Netherlands., Klein S; Clinical Pharmacology, Bayer AG Research and Development, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany., Francke K; Clinical Pharmacology, Bayer AG Research and Development, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany., Rottmann A; Clinical Pharmacology, Bayer AG Research and Development, Pharmaceuticals, Müllerstraße 178, 13353, Berlin, Germany.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Jan; Vol. 49 (1), pp. 71-85. Date of Electronic Publication: 2023 Dec 03.
Publikováno v:
In Ocean and Coastal Management November 2015 116:478-490
Autor:
Lücking U; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Kosemund D; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Böhnke N; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Lienau P; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Siemeister G; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Denner K; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Bohlmann R; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Briem H; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Terebesi I; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Bömer U; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Schäfer M; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Ince S; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Mumberg D; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Scholz A; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany., Izumi R; Vincerx Pharma, Inc., 260 Sheridan Avenue, Suite 400, Palo Alto, California 94306, United States., Hwang S; Vincerx Pharma, Inc., 260 Sheridan Avenue, Suite 400, Palo Alto, California 94306, United States., von Nussbaum F; Pharmaceuticals, Research and Development, Bayer Pharma AG, Müllerstr. 178, Berlin 13353, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Aug 12; Vol. 64 (15), pp. 11651-11674. Date of Electronic Publication: 2021 Jul 15.
Autor:
Taavitsainen P; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Prien O; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Kähkönen M; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Niehues M; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Korjamo T; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Denner K; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Nykänen P; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Vuorela A; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Jungmann NA; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., von Bühler CJ; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Koskinen M; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Zurth C; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.)., Gieschen H; Orion Corporation Orion Pharma, Turku, Finland (P.T.); Bayer AG, Berlin, Germany (O.P., M.N., K.D., C.Z., H.G.); Orion Corporation Orion Pharma, Espoo, Finland (M.K., T.K., P.N., A.V., M.K.); and Bayer AG, Wuppertal, Germany (N.A.J., C.-J.v.B.) hille.gieschen@bayer.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2021 Jun; Vol. 49 (6), pp. 420-433. Date of Electronic Publication: 2021 Mar 30.
Autor:
Lee, Jangsoon1,2,3 (AUTHOR) jlee@cc.hawaii.edu, Kida, Kumiko1,4 (AUTHOR), Koh, Jiwon5,6 (AUTHOR), Liu, Huey1 (AUTHOR), Manyam, Ganiraju C.7 (AUTHOR), Gi, Young Jin1,2 (AUTHOR), Rampa, Dileep R.2 (AUTHOR), Multani, Asha S.8 (AUTHOR), Wang, Jing8 (AUTHOR), Jayachandran, Gitanjali9 (AUTHOR), Lee, Dae-Won5,10 (AUTHOR), Reuben, James M.9 (AUTHOR), Sahin, Aysegul11 (AUTHOR), Huo, Lei11 (AUTHOR), Tripathy, Debu1 (AUTHOR), Im, Seock-Ah5,10 (AUTHOR) moisa@snu.ac.kr, Ueno, Naoto T.1,2 (AUTHOR) nueno@cc.hawaii.edu
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 8/20/2024, Vol. 43 Issue 1, p1-20. 20p.
Autor:
Mahajan, Radhika Rajiv1 (AUTHOR) p20200469@hyderabad.bits-pilani.ac.in, Ravi, Punna Rao1 (AUTHOR) h20211460240h@alumni.bits-pilani.ac.in, Marathe, Riya Kamlesh1 (AUTHOR) h20211460249h@alumni.bits-pilani.ac.in, Dongare, Ajay Gorakh1 (AUTHOR) h20211460252h@alumni.bits-pilani.ac.in, Prabhu, Apoorva Vinayak1 (AUTHOR), Szeleszczuk, Łukasz2 (AUTHOR) lukasz.szeleszczuk@wum.edu.pl
Publikováno v:
Pharmaceutics. Aug2024, Vol. 16 Issue 8, p1087. 23p.
Autor:
Paglialunga, Sabina1 (AUTHOR), Benrimoh, Natacha2 (AUTHOR), van Haarst, Aernout3 (AUTHOR) aernout.vanhaarst@celerion.com
Publikováno v:
Pharmaceutics. Aug2024, Vol. 16 Issue 8, p992. 12p.
Autor:
Lücking U; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Wortmann L; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Wengner AM; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Lefranc J; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Lienau P; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Briem H; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Siemeister G; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Bömer U; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Denner K; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Schäfer M; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Koppitz M; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Eis K; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Bartels F; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Bader B; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Bone W; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Moosmayer D; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Holton SJ; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Eberspächer U; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Grudzinska-Goebel J; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Schatz C; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Deeg G; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., Mumberg D; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany., von Nussbaum F; Research & Development, Pharmaceuticals, Bayer AG, 13353 Berlin, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Jul 09; Vol. 63 (13), pp. 7293-7325. Date of Electronic Publication: 2020 Jun 28.